MorphoSys Upbeat Despite Partner Failures In Alzheimer's And Rheumatoid Arthritis
High Hopes For Myelofibrosis Candidate Pelabresib
Monjuvi is still struggling to make progress commercially and the hopes of lucrative royalty streams from partners Roche and GSK have dried up but MorphoSys is keeping faith in its fully owned pipeline.
